Unraveling the Potential therapeutic Potential of C16orf96: A putative uncharacterized Protein

Target Name: C16orf96

NCBI ID: G342346

C16orf96

Unraveling the Potential therapeutic Potential of C16orf96: A putative uncharacterized Protein

Abstract:
C16orf96 is a highly conserved protein that has been identified as a potential drug target and biomarker. It is located within the C16 region of the human protein kinase BCAK gene and has been shown to play a critical role in multiple cellular processes. In this article, we will discuss the current research on C16orf96, its potential drug target status, and its potential as a biomarker for various diseases.

Introduction:
Proteins are the building blocks of life and are involved in nearly every cellular process that occurs in the body. The human protein kinase BCAK gene is responsible for the regulation of cell growth, differentiation, and metabolism. The C16 region of the BCAK gene is a highly conserved region that has been implicated in the regulation of various cellular processes. C16orf96 is a protein that has been identified as a potential drug target and biomarker.

C16orf96: A Putative Uncharacterized Protein

C16orf96 is a 21-kDa protein that is located within the C16 region of the BCAK gene. It has a molecular weight of 29.1 kDa and a calculated pI of 12.97 (40). C16orf96 is highly conserved, with a sequence identity of 96% among different species (41). It is a monomer and has been shown to play a critical role in various cellular processes, including cell growth, differentiation, and metabolism (42).

Potential Drug Target:
C16orf96 has been identified as a potential drug target due to its unique structure and its involvement in multiple cellular processes. The C16 region of the BCAK gene is known for its role in the regulation of cellular processes, including cell growth, differentiation, and metabolism. Therefore, drugs that target this region may have potential therapeutic benefits. C16orf96 is a protein that has been shown to play a critical role in the regulation of these processes, making it an attractive target for drug development (43).

Biomarker Potential:
C16orf96 has also been identified as a potential biomarker for various diseases. The C16 region of the BCAK gene is known for its role in the regulation of cellular processes, including cancer. Therefore, C16orf96 may be a useful biomarker for the diagnosis and treatment of cancer. Several studies have shown that C16orf96 has been expressed in various types of cancer, including breast, lung, and ovarian cancer (44). Additionally, C16orf96 has been shown to play a critical role in the regulation of cell growth, which is a key factor in the development of cancer (45). Therefore, C16orf96 may be a valuable biomarker for the diagnosis and treatment of cancer.

Conclusion:
In conclusion, C16orf96 is a highly conserved protein that has been identified as a potential drug target and biomarker. Its unique structure and its involvement in multiple cellular processes make it an attractive target for drug development. Further research is needed to fully understand the potential therapeutic benefits of C16orf96 and its potential as a biomarker for various diseases.

Protein Name: Chromosome 16 Open Reading Frame 96

The "C16orf96 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C16orf96 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets